Relenza, NDC# 00173-0681-22
Award Notice Posted
- Solicitation number
- Relenza
- Agency
-
Office of the Assistant Secretary for Administration
Department of Health and Human Services
- Awarded
- Set-aside
- 8(a) Sole Source
Opportunity facts
- Contract number
- Relenza-75P00224P000XX
- NAICS code
- 325414 Biological Product (except Diagnostic) Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Place of performance
- Perry Point, Maryland 21902, United States
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
This Award Notice announces the award of a contract for the supply of 9,520 packages of 'Relenza' (Zanamivir inhalant powder, 5mg, 20s, NDC# 00173-0681-22) to GLAXOSMITHKLINE, LLC for $249,900. The contract was awarded by the Department of Health and Human Services Office of the Assistant Secretary for Administration, a civilian federal agency, under an 8(a) Sole Source set-aside. The award was made on July 23, 2024.
Notice text
'Relenza', Zanamivir inhalant powder, 5mg, 20s, NDC# 00173-0681-22, quantity 9,520 packages.
Awarded contract Relenza to GLAXOSMITHKLINE, LLC for 249900.00 on 2024-07-23.
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity